{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:32:51Z","timestamp":1787826771799,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372075"],"award-info":[{"award-number":["82372075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371911"],"award-info":[{"award-number":["82371911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402415"],"award-info":[{"award-number":["82402415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Medical Innovation and Practice Research Program of Guangzhou","award":["2023QNYXYB009"],"award-info":[{"award-number":["2023QNYXYB009"]}]},{"name":"Natural Science Outstanding Youth Fund Project of Guangdong province,China","award":["2024B1515020061"],"award-info":[{"award-number":["2024B1515020061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11773-0","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:12:59Z","timestamp":1751278379000},"page":"219-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multiparametric MRI for assessing residual tumors in patients with muscle-invasive bladder cancer after neoadjuvant treatment: a reliable tool for guiding bladder preservation"],"prefix":"10.1007","volume":"36","author":[{"given":"Qian","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-7736","authenticated-orcid":false,"given":"Huanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"11773_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71:96\u2013108","journal-title":"Eur Urol"},{"key":"11773_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","volume":"18","author":"TW Flaig","year":"2020","unstructured":"Flaig TW, Spiess PE, Agarwal N et al (2020) Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 18:329\u2013354","journal-title":"J Natl Compr Cancer Netw"},{"key":"11773_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM et al (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859\u2013866","journal-title":"N Engl J Med"},{"key":"11773_CR4","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/JCO.18.01148","volume":"36","author":"A Necchi","year":"2018","unstructured":"Necchi A, Anichini A, Raggi D et al (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol 36:3353\u20133360","journal-title":"J Clin Oncol"},{"key":"11773_CR5","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3390\/cancers14102545","volume":"14","author":"B Barone","year":"2022","unstructured":"Barone B, Calogero A, Scafuri L et al (2022) Immune checkpoint inhibitors as a neoadjuvant\/adjuvant treatment of muscle-invasive bladder cancer: a systematic review. Cancers (Basel) 14:2545","journal-title":"Cancers (Basel)"},{"key":"11773_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.urology.2009.06.111","volume":"75","author":"S Yoshida","year":"2010","unstructured":"Yoshida S, Koga F, Kawakami S et al (2010) Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 75:387\u2013391","journal-title":"Urology"},{"key":"11773_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0037-198X(05)80008-2","volume":"30","author":"P Ramchandani","year":"1995","unstructured":"Ramchandani P, Pollack HM (1995) Radiology of drug-related genitourinary disease. Semin Roentgenol 30:77\u201387","journal-title":"Semin Roentgenol"},{"key":"11773_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2214\/ajr.180.4.1801045","volume":"180","author":"V Kundra","year":"2003","unstructured":"Kundra V, Silverman PM (2003) Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol 180:1045\u20131054","journal-title":"AJR Am J Roentgenol"},{"key":"11773_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/MOU.0b013e32833cc9f4","volume":"20","author":"G Gakis","year":"2010","unstructured":"Gakis G, Kruck S, Stenzl A (2010) Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers? Current Opinion Urology 20:388\u2013392","journal-title":"Current Opinion Urology"},{"key":"11773_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1148\/radiol.220028","volume":"304","author":"Q Cai","year":"2022","unstructured":"Cai Q, Ling J, Kong L et al (2022) Multiparametric MRI evaluation of VI-RADS for bladder tumors located at the ureteral orifice. Radiology 304:593\u2013599","journal-title":"Radiology"},{"key":"11773_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","volume":"77","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice F, Barchetti G, De Berardinis E et al (2020) Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur Urol 77:101\u2013109","journal-title":"Eur Urol"},{"key":"11773_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1148\/radiol.2019182506","volume":"291","author":"H Wang","year":"2019","unstructured":"Wang H, Luo C, Zhang F et al (2019) Multiparametric MRI for bladder cancer: validation of vi-rads for the detection of detrusor muscle invasion. Radiology 291:668\u2013674","journal-title":"Radiology"},{"key":"11773_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/RCT.0000000000000363","volume":"40","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Ego-Osuala IO, Khalef V, Deng FM, Taneja SS, Huang WC (2016) Investigation of multisequence magnetic resonance imaging for detection of recurrent tumor after transurethral resection for bladder cancer. J Comput Assist Tomogr 40:201\u2013205","journal-title":"J Comput Assist Tomogr"},{"key":"11773_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2214\/AJR.14.13147","volume":"204","author":"HJ Wang","year":"2015","unstructured":"Wang HJ, Pui MH, Guo Y et al (2015) Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. AJR Am J Roentgenol 204:330\u2013334","journal-title":"AJR Am J Roentgenol"},{"key":"11773_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.eururo.2019.12.016","volume":"77","author":"A Necchi","year":"2020","unstructured":"Necchi A, Bandini M, Calareso G et al (2020) Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: preliminary findings from the PURE-01 study. Eur Urol 77:636\u2013643","journal-title":"Eur Urol"},{"key":"11773_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","volume":"47","author":"M Pecoraro","year":"2021","unstructured":"Pecoraro M, Del Giudice F, Magliocca F et al (2021) Vesical imaging-reporting and data system (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom Radiol (NY) 47:763\u2013770","journal-title":"Abdom Radiol (NY)"},{"key":"11773_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system). Eur Urol 74:294\u2013306","journal-title":"Eur Urol"},{"key":"11773_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ejrnm.2014.04.013","volume":"45","author":"M Eid","year":"2014","unstructured":"Eid M, Abougabal A (2014) Subtraction images: a really helpful tool in non-vascular MRI. Egypt J Radiol Nucl Med 45:909\u2013919","journal-title":"Egypt J Radiol Nucl Med"},{"key":"11773_CR19","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1007\/s00261-021-02963-7","volume":"46","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Taher M, Ali W, Ebrahem M (2021) Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer. Abdom Radiol (NY) 46:2712\u20132721","journal-title":"Abdom Radiol (NY)"},{"key":"11773_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ejrad.2015.02.026","volume":"84","author":"C Chakiba","year":"2015","unstructured":"Chakiba C, Cornelis F, Descat E et al (2015) Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma. Eur J Radiol 84:1023\u20131028","journal-title":"Eur J Radiol"},{"key":"11773_CR21","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.ijrobp.2011.11.065","volume":"83","author":"S Yoshida","year":"2012","unstructured":"Yoshida S, Koga F, Kobayashi S et al (2012) Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83:e21\u2013e27","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11773_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bju.16191","volume":"133","author":"A Necchi","year":"2023","unstructured":"Necchi A, Basile G, Gibb EA et al (2023) Vesical imaging-reporting and data system use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer. BJU Int 133:214\u2013222","journal-title":"BJU Int"},{"key":"11773_CR23","doi-asserted-by":"publisher","first-page":"108902","DOI":"10.1016\/j.ejrad.2020.108902","volume":"126","author":"SJ Choi","year":"2020","unstructured":"Choi SJ, Park KJ, Lee G, Kim MH, Kim JK (2020) Urothelial phase CT for assessment of pathologic complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer. Eur J Radiol 126:108902","journal-title":"Eur J Radiol"},{"key":"11773_CR24","doi-asserted-by":"publisher","first-page":"e233020","DOI":"10.1148\/radiol.233020","volume":"313","author":"G Brembilla","year":"2024","unstructured":"Brembilla G, Basile G, Cosenza M et al (2024) Neoadjuvant chemotherapy VI-RADS scores for assessing muscle-invasive bladder cancer response to neoadjuvant immunotherapy with multiparametric MRI. Radiology 313:e233020","journal-title":"Radiology"},{"key":"11773_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijrobp.2023.07.027","volume":"118","author":"K Br\u00fcck","year":"2024","unstructured":"Br\u00fcck K, Meijer RP, Boormans JL et al (2024) Disease-free survival of patients with muscle-invasive bladder cancer treated with radical cystectomy versus bladder-preserving therapy: a nationwide study. Int J Radiat Oncol Biol Phys 118:41\u201349","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11773_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.euo.2023.02.008","volume":"6","author":"E Grobet-Jeandin","year":"2023","unstructured":"Grobet-Jeandin E, Lenfant L, Mir C et al (2023) A systematic review of oncological outcomes associated with bladder-sparing strategies in patients achieving complete clinical response to initial systemic treatment for localized muscle-invasive bladder cancer. Eur Urol Oncol 6:251\u2013262","journal-title":"Eur Urol Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11773-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11773-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11773-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:59:59Z","timestamp":1765979999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11773-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["11773"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11773-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Huanjun Wang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have not been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}